534 related articles for article (PubMed ID: 23422032)
21. High quality genome-wide genotyping from archived dried blood spots without DNA amplification.
St Julien KR; Jelliffe-Pawlowski LL; Shaw GM; Stevenson DK; O'Brodovich HM; Krasnow MA;
PLoS One; 2013; 8(5):e64710. PubMed ID: 23737996
[TBL] [Abstract][Full Text] [Related]
22. Stability of genomic DNA in dried blood spots stored on filter paper.
Chaisomchit S; Wichajarn R; Janejai N; Chareonsiriwatana W
Southeast Asian J Trop Med Public Health; 2005 Jan; 36(1):270-3. PubMed ID: 15906682
[TBL] [Abstract][Full Text] [Related]
23. Comparison of newborn screening protocols for congenital adrenal hyperplasia in preterm infants.
Sarafoglou K; Gaviglio A; Hietala A; Frogner G; Banks K; McCann M; Thomas W
J Pediatr; 2014 May; 164(5):1136-40. PubMed ID: 24582106
[TBL] [Abstract][Full Text] [Related]
24. High density FTA plates serve as efficient long-term sample storage for HLA genotyping.
Lange V; Arndt K; Schwarzelt C; Boehme I; Giani AS; Schmidt AH; Ehninger G; Wassmuth R
Tissue Antigens; 2014 Feb; 83(2):101-5. PubMed ID: 24397418
[TBL] [Abstract][Full Text] [Related]
25. Single tube multiplex PCR detection of 27 cystic fibrosis mutations and 4 polymorphisms using neonatal blood samples collected on Guthrie cards.
Makowski GS; Nadeau FL; Hopfer SM
Ann Clin Lab Sci; 2003; 33(3):243-50. PubMed ID: 12956437
[TBL] [Abstract][Full Text] [Related]
26. Minimally invasive genetic screen for GJB2 related deafness using dried blood spots.
Nagy AL; Csáki R; Klem J; Rovó L; Tóth F; Tálosi G; Jóri J; Kovács K; Kiss JG
Int J Pediatr Otorhinolaryngol; 2010 Jan; 74(1):75-81. PubMed ID: 19939467
[TBL] [Abstract][Full Text] [Related]
27. Isolation of human genomic DNA for genetic analysis from premature neonates: a comparison between newborn dried blood spots, whole blood and umbilical cord tissue.
Rajatileka S; Luyt K; El-Bokle M; Williams M; Kemp H; Molnár E; Váradi A
BMC Genet; 2013 Oct; 14():105. PubMed ID: 24168095
[TBL] [Abstract][Full Text] [Related]
28. Extended gene analysis can increase specificity of neonatal screening for cystic fibrosis.
Mérelle ME; Scheffer H; De Jong D; Dankert-Roelse JE
Acta Paediatr; 2006 Nov; 95(11):1424-8. PubMed ID: 17062471
[TBL] [Abstract][Full Text] [Related]
29. Storage and use of residual dried blood spots.
Webster D; ;
Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():49-51. PubMed ID: 15906694
[TBL] [Abstract][Full Text] [Related]
30. Short-term stability of amino acids and acylcarnitines in the dried blood spots used to screen newborns for metabolic disorders.
Golbahar J; Altayab DD; Carreon E
J Med Screen; 2014 Mar; 21(1):5-9. PubMed ID: 24531510
[TBL] [Abstract][Full Text] [Related]
31. Dried blood spots as a sampling technique for the quantitative determination of guanfacine in clinical studies.
Li Y; Henion J; Abbott R; Wang P
Bioanalysis; 2011 Nov; 3(22):2501-14. PubMed ID: 22122599
[TBL] [Abstract][Full Text] [Related]
32. The utility of post-test newborn blood spot screening cards for epigenetic association analyses: association between HIF3A methylation and birth weight-for-gestational age.
Zar Kyaw T; Yamaguchi S; Imai C; Uematsu M; Sato N
J Hum Genet; 2019 Aug; 64(8):795-801. PubMed ID: 31138846
[TBL] [Abstract][Full Text] [Related]
33. The dried blood spot sampling method in the laboratory medicine.
Andrlova L; Kandar R
Bratisl Lek Listy; 2019; 120(3):223-234. PubMed ID: 31023042
[TBL] [Abstract][Full Text] [Related]
34. Visual automated fluorescence electrophoresis provides simultaneous quality, quantity, and molecular weight spectra for genomic DNA from archived neonatal blood spots.
Klassen TL; Drabek J; Tomson T; Sveinsson O; von Döbeln U; Noebels JL; Goldman AM
J Mol Diagn; 2013 May; 15(3):283-90. PubMed ID: 23518217
[TBL] [Abstract][Full Text] [Related]
35. Dried Blood Spots, an Affordable Tool to Collect, Ship, and Sequence gDNA from Patients with an X-Linked Agammaglobulinemia Phenotype Residing in a Developing Country.
Segundo GRS; Nguyen ATV; Thuc HT; Nguyen LNQ; Kobayashi RH; Le HT; Le HTM; Torgerson TR; Ochs HD
Front Immunol; 2018; 9():289. PubMed ID: 29503650
[TBL] [Abstract][Full Text] [Related]
36. Biological specimen banks in neonatal screening.
Nørgaard-Pedersen B; Simonsen H
Acta Paediatr Suppl; 1999 Dec; 88(432):106-9. PubMed ID: 10626593
[TBL] [Abstract][Full Text] [Related]
37. Quality standards in Biobanking: authentication by genetic profiling of blood spots from donor's original sample.
Cardoso S; Valverde L; Odriozola A; Elcoroaristizabal X; de Pancorbo MM
Eur J Hum Genet; 2010 Jul; 18(7):848-51. PubMed ID: 20234395
[TBL] [Abstract][Full Text] [Related]
38. Archived Guthrie blood spots as a novel source for quantitative DNA methylation analysis.
Wong N; Morley R; Saffery R; Craig J
Biotechniques; 2008 Oct; 45(4):423-4, 426, 428 passim. PubMed ID: 18855769
[TBL] [Abstract][Full Text] [Related]
39. A three-step molecular protocol employing DNA obtained from dried blood spots for neonatal screening for 45,X Turner syndrome.
Rocha MN; Melo MR; Longui CA; de Oliveira DV; Figueiredo CC; Pacchi PR
Genet Mol Res; 2005 Dec; 4(4):749-54. PubMed ID: 16475121
[TBL] [Abstract][Full Text] [Related]
40. Bisulfite genomic sequencing of DNA from dried blood spot microvolume samples.
Xu H; Zhao Y; Liu Z; Zhu W; Zhou Y; Zhao Z
Forensic Sci Int Genet; 2012 May; 6(3):306-9. PubMed ID: 21737370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
